ANTITUMOR ACTIVITY OF PI3K ANTAGONIST AEZS126*IN MODELS OF TRIPLE NEGATIVE BREAST CANCER

被引:0
|
作者
Engel, J. B. [1 ]
Schmidt, H. [1 ]
Haeussler, S. [1 ]
Diessner, J. [1 ]
Hahne, J. [1 ]
Meyer, S. [1 ]
Wischhusen, J. [1 ]
Dietl, J. [1 ]
Hoenig, A. [1 ]
机构
[1] Univ Wurzburg, Dept Obstet & Gynecol, Wurzburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1967 / 1968
页数:2
相关论文
共 50 条
  • [31] Potentiating Alpelisib in PI3K Pathway Overactive Triple Negative Breast Cancers
    Boyd, David
    Harrell, Chuck
    CANCER RESEARCH, 2023, 83 (05)
  • [32] AEZS-132, a new orally bioavailable PI3K/Erk inhibitor with antitumor effects
    Seipelt, I.
    Gerlach, M.
    Baasner, S.
    Blumenstein, L.
    Mueller, G.
    Aicher, B.
    Engel, J.
    Guenther, E.
    Teifel, M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 66 - 66
  • [33] Rujifang inhibits triple-negative breast cancer growth via the PI3K/ AKT pathway
    Jia, Wenyu
    Lin, Xuan
    Chen, Xuezhang
    Li, Hongliang
    Zhang, Xingru
    Zhang, Yuzhuo
    Chen, Yinsong
    Wang, Bin
    Chen, Xikang
    Chen, Ju
    Tian, Huaqin
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 327
  • [34] Elucidating the role of functional signal transduction pathway activity in sensitivity and response of triple negative breast cancer to PI3K inhibition
    Guo, Z.
    Verhaegh, W.
    Hoog, J.
    Rajput, S.
    van Strijp, D.
    van de Stolpe, A.
    Li, S.
    Ma, C.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
    Solzak, J. P.
    Atale, R.
    Hancock, B. A.
    Radovich, M.
    CANCER RESEARCH, 2013, 73
  • [37] Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer
    Johnson, Jeremy
    Chow, Zeta
    Napier, Dana
    Lee, Eun
    Weiss, Heidi L.
    Evers, B. Mark
    Rychahou, Piotr
    CELLS, 2020, 9 (05)
  • [38] Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway
    Park, Yeon Hee
    Jung, Hae Hyun
    Ahn, Jin Seok
    Im, Young-Hyuck
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 439 (02) : 275 - 279
  • [39] Insights into the compensation mechanism behind targeting PI3K and Wnt in triple-negative breast cancer
    Solzak, Jeffrey P.
    Wang, Chao
    Radovich, Milan
    CANCER RESEARCH, 2022, 82 (04)
  • [40] Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
    Solzak, Jeffrey P.
    Atale, Rutuja V.
    Hancock, Bradley A.
    Sinn, Anthony L.
    Pollok, Karen E.
    Jones, David R.
    Radovich, Milan
    NPJ BREAST CANCER, 2017, 3